MARKET

APUS

APUS

APIMEDS PHARMACEUTICALS US INC
AMEX
5.65
-0.11
-1.95%
Opening 09:30 07/27 EDT
OPEN
6.14
PREV CLOSE
5.65
HIGH
6.14
LOW
6.14
VOLUME
31
TURNOVER
49
52 WEEK HIGH
59.70
52 WEEK LOW
5.44
MARKET CAP
8.53M
P/E (TTM)
-0.8918
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at APUS last week (0720-0724)?
Weekly Report · 3h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 5d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 6d ago
Weekly Report: what happened at APUS last week (0713-0717)?
Weekly Report · 07/20 09:38
Upcoming Stock Splits This Week (July 20 to July 24) – Stay Invested
TipRanks · 07/19 17:20
Apimeds Pharmaceuticals to Implement Reverse Stock Split July 24
TipRanks · 07/13 21:02
Weekly Report: what happened at APUS last week (0706-0710)?
Weekly Report · 07/13 09:39
Weekly Report: what happened at APUS last week (0629-0703)?
Weekly Report · 07/06 09:41
More
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.

Webull offers Apimeds Pharmaceuticals US, Inc. stock information, including AMEX: APUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APUS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APUS stock methods without spending real money on the virtual paper trading platform.